New approach to chronic lymphocytic leukemia treatment

A novel and unique approach to treating Chronic Lymphocytic Leukemia (CLL), a form of blood cancer that often requires repeated chemotherapy treatments to which it grows resistant, as been developed by scientists. Unlike other novel therapies that have shown promise in the treatment of CLL, this approach is unique because it does not directly target proteins within the B-cell receptor pathway, but instead uses novel model systems that reverse the pro-survival effects of the microenvironment.

by via Latest Science News -- ScienceDaily